These experiments suggest that in the tumor microenvironment, cytokines secreted by tumor cells inhibit the differentiation of CD34+ bone marrow stem cells into DCs, while negatively regulated DCs increase tumor aggressiveness (33). The gene discussed is CD34; the disease is neoplasm.